Loading…

Biochemical profile of renal amyloidosis in a Latin American cohort

Background Two-thirds of patients with immunoglobulin light chain (AL) amyloidosis have renal involvement. The biochemical profile of kidney damage is poorly described. Methods A cross-sectional study was conducted involving patients diagnosed with AL amyloidosis and renal involvement between Januar...

Full description

Saved in:
Bibliographic Details
Published in:Journal of nephrology 2024-11, Vol.37 (8), p.2351-2354
Main Authors: Carretero, Marcelina, Minoletti, Sofia Antonella, Aguirre, María Adela, Nucifora, Elsa Mercedes, Sáez, María Sáez, Martínez, María Lourdes Posadas
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c228t-b397260c01385b563a28c27be7d736ebdc8d63b56bfdae4bcd98c1bac53dc5d43
container_end_page 2354
container_issue 8
container_start_page 2351
container_title Journal of nephrology
container_volume 37
creator Carretero, Marcelina
Minoletti, Sofia Antonella
Aguirre, María Adela
Nucifora, Elsa Mercedes
Sáez, María Sáez
Martínez, María Lourdes Posadas
description Background Two-thirds of patients with immunoglobulin light chain (AL) amyloidosis have renal involvement. The biochemical profile of kidney damage is poorly described. Methods A cross-sectional study was conducted involving patients diagnosed with AL amyloidosis and renal involvement between January 1, 2010, and April 30, 2022 at the Hospital Italiano de Buenos Aires. Participants were retrospectively identified from the Institutional Amyloidosis Registry. Patients diagnosed with AL amyloidosis and evidence of renal involvement were included. Individuals with other types of amyloidosis were excluded. The selection process involved a thorough review of medical records and registry data to ensure accurate identification and inclusion of eligible participants. Results Seventy-seven patients were included. At diagnosis, 90% of the subjects had proteinuria, with a median of 4.3 g/24 h, 61% had renal failure, and 47% presented nephrotic syndrome. Semi-automated urinary electrophoresis revealed 55% with non-selective and 21% with moderately selective glomerular proteinuria. Urine immunofixation indicated 64% with lambda monoclonal free light chains and 12% with kappa. Serum immunofixation demonstrated 48% with lambda monoclonal type and 25% with lambda IgG. At the time of diagnosis of AL amyloidosis, the median age was 66 years (IQR 53–72) and 49% were men. In addition to kidney involvement, other organs were also affected: heart in 53%, gastrointestinal system in 19%, peripheral nervous system in 16%, and liver in 16% of patients. Conclusion Our study provides a biochemical profile in renal amyloidosis due to immunoglobulin light chains in a Latin American population. Proteinuria emerged as the most common finding in this cohort with frequent multiorgan involvement. Graphical abstract
doi_str_mv 10.1007/s40620-024-02046-y
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3100275648</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3100275648</sourcerecordid><originalsourceid>FETCH-LOGICAL-c228t-b397260c01385b563a28c27be7d736ebdc8d63b56bfdae4bcd98c1bac53dc5d43</originalsourceid><addsrcrecordid>eNp9kDtPwzAUhS0EoqXwBxiQR5aAY8d2MpaIl1SJBWbLr1BXSVzsZMi_x5CCmBiu7r2-5xxZHwCXObrJEeK3sUAMowzhIhUqWDYdgWXO08oQrY7_zAtwFuMOIUwpLk7BglQY04pXS1DfOa-3tnNatnAffONaC30Dg-3Tg-ym1jvjo4vQ9VDCjRxSX3c2JEMPtd_6MJyDk0a20V4c-gq8Pdy_1k_Z5uXxuV5vMo1xOWSKVBwzpFFOSqooIxKXGnNlueGEWWV0aRhJB9UYaQulTVXqXElNidHUFGQFrufc9M-P0cZBdC5q27ayt36MgiQqmFNWlEmKZ6kOPsZgG7EPrpNhEjkSX_DEDE8keOIbnpiS6eqQP6rOml_LD60kILMgplP_boPY-TEkUPG_2E87O3r0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3100275648</pqid></control><display><type>article</type><title>Biochemical profile of renal amyloidosis in a Latin American cohort</title><source>Springer Nature</source><creator>Carretero, Marcelina ; Minoletti, Sofia Antonella ; Aguirre, María Adela ; Nucifora, Elsa Mercedes ; Sáez, María Sáez ; Martínez, María Lourdes Posadas</creator><creatorcontrib>Carretero, Marcelina ; Minoletti, Sofia Antonella ; Aguirre, María Adela ; Nucifora, Elsa Mercedes ; Sáez, María Sáez ; Martínez, María Lourdes Posadas</creatorcontrib><description>Background Two-thirds of patients with immunoglobulin light chain (AL) amyloidosis have renal involvement. The biochemical profile of kidney damage is poorly described. Methods A cross-sectional study was conducted involving patients diagnosed with AL amyloidosis and renal involvement between January 1, 2010, and April 30, 2022 at the Hospital Italiano de Buenos Aires. Participants were retrospectively identified from the Institutional Amyloidosis Registry. Patients diagnosed with AL amyloidosis and evidence of renal involvement were included. Individuals with other types of amyloidosis were excluded. The selection process involved a thorough review of medical records and registry data to ensure accurate identification and inclusion of eligible participants. Results Seventy-seven patients were included. At diagnosis, 90% of the subjects had proteinuria, with a median of 4.3 g/24 h, 61% had renal failure, and 47% presented nephrotic syndrome. Semi-automated urinary electrophoresis revealed 55% with non-selective and 21% with moderately selective glomerular proteinuria. Urine immunofixation indicated 64% with lambda monoclonal free light chains and 12% with kappa. Serum immunofixation demonstrated 48% with lambda monoclonal type and 25% with lambda IgG. At the time of diagnosis of AL amyloidosis, the median age was 66 years (IQR 53–72) and 49% were men. In addition to kidney involvement, other organs were also affected: heart in 53%, gastrointestinal system in 19%, peripheral nervous system in 16%, and liver in 16% of patients. Conclusion Our study provides a biochemical profile in renal amyloidosis due to immunoglobulin light chains in a Latin American population. Proteinuria emerged as the most common finding in this cohort with frequent multiorgan involvement. Graphical abstract</description><identifier>ISSN: 1724-6059</identifier><identifier>EISSN: 1724-6059</identifier><identifier>DOI: 10.1007/s40620-024-02046-y</identifier><identifier>PMID: 39225979</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Aged ; Amyloidosis - diagnosis ; Amyloidosis - epidemiology ; Argentina - epidemiology ; Biomarkers - blood ; Biomarkers - urine ; Cross-Sectional Studies ; Female ; Humans ; Immunoglobulin kappa-Chains - analysis ; Immunoglobulin kappa-Chains - blood ; Immunoglobulin kappa-Chains - urine ; Immunoglobulin lambda-Chains - blood ; Immunoglobulin Light-chain Amyloidosis - blood ; Immunoglobulin Light-chain Amyloidosis - diagnosis ; Immunoglobulin Light-chain Amyloidosis - epidemiology ; Immunoglobulin Light-chain Amyloidosis - urine ; Kidney Diseases - diagnosis ; Kidney Diseases - epidemiology ; Kidney Diseases - etiology ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Nephrology ; Nephrology Crossing Borders ; Nephrotic Syndrome - urine ; Proteinuria - etiology ; Registries ; Retrospective Studies ; Urology</subject><ispartof>Journal of nephrology, 2024-11, Vol.37 (8), p.2351-2354</ispartof><rights>The Author(s) under exclusive licence to Italian Society of Nephrology 2024</rights><rights>2024. The Author(s) under exclusive licence to Italian Society of Nephrology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c228t-b397260c01385b563a28c27be7d736ebdc8d63b56bfdae4bcd98c1bac53dc5d43</cites><orcidid>0000-0003-2259-5626 ; 0000-0001-9690-2284 ; 0000-0003-2177-7727 ; 0000-0002-7905-7549 ; 0000-0003-1403-7069</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39225979$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carretero, Marcelina</creatorcontrib><creatorcontrib>Minoletti, Sofia Antonella</creatorcontrib><creatorcontrib>Aguirre, María Adela</creatorcontrib><creatorcontrib>Nucifora, Elsa Mercedes</creatorcontrib><creatorcontrib>Sáez, María Sáez</creatorcontrib><creatorcontrib>Martínez, María Lourdes Posadas</creatorcontrib><title>Biochemical profile of renal amyloidosis in a Latin American cohort</title><title>Journal of nephrology</title><addtitle>J Nephrol</addtitle><addtitle>J Nephrol</addtitle><description>Background Two-thirds of patients with immunoglobulin light chain (AL) amyloidosis have renal involvement. The biochemical profile of kidney damage is poorly described. Methods A cross-sectional study was conducted involving patients diagnosed with AL amyloidosis and renal involvement between January 1, 2010, and April 30, 2022 at the Hospital Italiano de Buenos Aires. Participants were retrospectively identified from the Institutional Amyloidosis Registry. Patients diagnosed with AL amyloidosis and evidence of renal involvement were included. Individuals with other types of amyloidosis were excluded. The selection process involved a thorough review of medical records and registry data to ensure accurate identification and inclusion of eligible participants. Results Seventy-seven patients were included. At diagnosis, 90% of the subjects had proteinuria, with a median of 4.3 g/24 h, 61% had renal failure, and 47% presented nephrotic syndrome. Semi-automated urinary electrophoresis revealed 55% with non-selective and 21% with moderately selective glomerular proteinuria. Urine immunofixation indicated 64% with lambda monoclonal free light chains and 12% with kappa. Serum immunofixation demonstrated 48% with lambda monoclonal type and 25% with lambda IgG. At the time of diagnosis of AL amyloidosis, the median age was 66 years (IQR 53–72) and 49% were men. In addition to kidney involvement, other organs were also affected: heart in 53%, gastrointestinal system in 19%, peripheral nervous system in 16%, and liver in 16% of patients. Conclusion Our study provides a biochemical profile in renal amyloidosis due to immunoglobulin light chains in a Latin American population. Proteinuria emerged as the most common finding in this cohort with frequent multiorgan involvement. Graphical abstract</description><subject>Aged</subject><subject>Amyloidosis - diagnosis</subject><subject>Amyloidosis - epidemiology</subject><subject>Argentina - epidemiology</subject><subject>Biomarkers - blood</subject><subject>Biomarkers - urine</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulin kappa-Chains - analysis</subject><subject>Immunoglobulin kappa-Chains - blood</subject><subject>Immunoglobulin kappa-Chains - urine</subject><subject>Immunoglobulin lambda-Chains - blood</subject><subject>Immunoglobulin Light-chain Amyloidosis - blood</subject><subject>Immunoglobulin Light-chain Amyloidosis - diagnosis</subject><subject>Immunoglobulin Light-chain Amyloidosis - epidemiology</subject><subject>Immunoglobulin Light-chain Amyloidosis - urine</subject><subject>Kidney Diseases - diagnosis</subject><subject>Kidney Diseases - epidemiology</subject><subject>Kidney Diseases - etiology</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Nephrology</subject><subject>Nephrology Crossing Borders</subject><subject>Nephrotic Syndrome - urine</subject><subject>Proteinuria - etiology</subject><subject>Registries</subject><subject>Retrospective Studies</subject><subject>Urology</subject><issn>1724-6059</issn><issn>1724-6059</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kDtPwzAUhS0EoqXwBxiQR5aAY8d2MpaIl1SJBWbLr1BXSVzsZMi_x5CCmBiu7r2-5xxZHwCXObrJEeK3sUAMowzhIhUqWDYdgWXO08oQrY7_zAtwFuMOIUwpLk7BglQY04pXS1DfOa-3tnNatnAffONaC30Dg-3Tg-ym1jvjo4vQ9VDCjRxSX3c2JEMPtd_6MJyDk0a20V4c-gq8Pdy_1k_Z5uXxuV5vMo1xOWSKVBwzpFFOSqooIxKXGnNlueGEWWV0aRhJB9UYaQulTVXqXElNidHUFGQFrufc9M-P0cZBdC5q27ayt36MgiQqmFNWlEmKZ6kOPsZgG7EPrpNhEjkSX_DEDE8keOIbnpiS6eqQP6rOml_LD60kILMgplP_boPY-TEkUPG_2E87O3r0</recordid><startdate>20241101</startdate><enddate>20241101</enddate><creator>Carretero, Marcelina</creator><creator>Minoletti, Sofia Antonella</creator><creator>Aguirre, María Adela</creator><creator>Nucifora, Elsa Mercedes</creator><creator>Sáez, María Sáez</creator><creator>Martínez, María Lourdes Posadas</creator><general>Springer International Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2259-5626</orcidid><orcidid>https://orcid.org/0000-0001-9690-2284</orcidid><orcidid>https://orcid.org/0000-0003-2177-7727</orcidid><orcidid>https://orcid.org/0000-0002-7905-7549</orcidid><orcidid>https://orcid.org/0000-0003-1403-7069</orcidid></search><sort><creationdate>20241101</creationdate><title>Biochemical profile of renal amyloidosis in a Latin American cohort</title><author>Carretero, Marcelina ; Minoletti, Sofia Antonella ; Aguirre, María Adela ; Nucifora, Elsa Mercedes ; Sáez, María Sáez ; Martínez, María Lourdes Posadas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c228t-b397260c01385b563a28c27be7d736ebdc8d63b56bfdae4bcd98c1bac53dc5d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Amyloidosis - diagnosis</topic><topic>Amyloidosis - epidemiology</topic><topic>Argentina - epidemiology</topic><topic>Biomarkers - blood</topic><topic>Biomarkers - urine</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulin kappa-Chains - analysis</topic><topic>Immunoglobulin kappa-Chains - blood</topic><topic>Immunoglobulin kappa-Chains - urine</topic><topic>Immunoglobulin lambda-Chains - blood</topic><topic>Immunoglobulin Light-chain Amyloidosis - blood</topic><topic>Immunoglobulin Light-chain Amyloidosis - diagnosis</topic><topic>Immunoglobulin Light-chain Amyloidosis - epidemiology</topic><topic>Immunoglobulin Light-chain Amyloidosis - urine</topic><topic>Kidney Diseases - diagnosis</topic><topic>Kidney Diseases - epidemiology</topic><topic>Kidney Diseases - etiology</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Nephrology</topic><topic>Nephrology Crossing Borders</topic><topic>Nephrotic Syndrome - urine</topic><topic>Proteinuria - etiology</topic><topic>Registries</topic><topic>Retrospective Studies</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carretero, Marcelina</creatorcontrib><creatorcontrib>Minoletti, Sofia Antonella</creatorcontrib><creatorcontrib>Aguirre, María Adela</creatorcontrib><creatorcontrib>Nucifora, Elsa Mercedes</creatorcontrib><creatorcontrib>Sáez, María Sáez</creatorcontrib><creatorcontrib>Martínez, María Lourdes Posadas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carretero, Marcelina</au><au>Minoletti, Sofia Antonella</au><au>Aguirre, María Adela</au><au>Nucifora, Elsa Mercedes</au><au>Sáez, María Sáez</au><au>Martínez, María Lourdes Posadas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biochemical profile of renal amyloidosis in a Latin American cohort</atitle><jtitle>Journal of nephrology</jtitle><stitle>J Nephrol</stitle><addtitle>J Nephrol</addtitle><date>2024-11-01</date><risdate>2024</risdate><volume>37</volume><issue>8</issue><spage>2351</spage><epage>2354</epage><pages>2351-2354</pages><issn>1724-6059</issn><eissn>1724-6059</eissn><abstract>Background Two-thirds of patients with immunoglobulin light chain (AL) amyloidosis have renal involvement. The biochemical profile of kidney damage is poorly described. Methods A cross-sectional study was conducted involving patients diagnosed with AL amyloidosis and renal involvement between January 1, 2010, and April 30, 2022 at the Hospital Italiano de Buenos Aires. Participants were retrospectively identified from the Institutional Amyloidosis Registry. Patients diagnosed with AL amyloidosis and evidence of renal involvement were included. Individuals with other types of amyloidosis were excluded. The selection process involved a thorough review of medical records and registry data to ensure accurate identification and inclusion of eligible participants. Results Seventy-seven patients were included. At diagnosis, 90% of the subjects had proteinuria, with a median of 4.3 g/24 h, 61% had renal failure, and 47% presented nephrotic syndrome. Semi-automated urinary electrophoresis revealed 55% with non-selective and 21% with moderately selective glomerular proteinuria. Urine immunofixation indicated 64% with lambda monoclonal free light chains and 12% with kappa. Serum immunofixation demonstrated 48% with lambda monoclonal type and 25% with lambda IgG. At the time of diagnosis of AL amyloidosis, the median age was 66 years (IQR 53–72) and 49% were men. In addition to kidney involvement, other organs were also affected: heart in 53%, gastrointestinal system in 19%, peripheral nervous system in 16%, and liver in 16% of patients. Conclusion Our study provides a biochemical profile in renal amyloidosis due to immunoglobulin light chains in a Latin American population. Proteinuria emerged as the most common finding in this cohort with frequent multiorgan involvement. Graphical abstract</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>39225979</pmid><doi>10.1007/s40620-024-02046-y</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-2259-5626</orcidid><orcidid>https://orcid.org/0000-0001-9690-2284</orcidid><orcidid>https://orcid.org/0000-0003-2177-7727</orcidid><orcidid>https://orcid.org/0000-0002-7905-7549</orcidid><orcidid>https://orcid.org/0000-0003-1403-7069</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1724-6059
ispartof Journal of nephrology, 2024-11, Vol.37 (8), p.2351-2354
issn 1724-6059
1724-6059
language eng
recordid cdi_proquest_miscellaneous_3100275648
source Springer Nature
subjects Aged
Amyloidosis - diagnosis
Amyloidosis - epidemiology
Argentina - epidemiology
Biomarkers - blood
Biomarkers - urine
Cross-Sectional Studies
Female
Humans
Immunoglobulin kappa-Chains - analysis
Immunoglobulin kappa-Chains - blood
Immunoglobulin kappa-Chains - urine
Immunoglobulin lambda-Chains - blood
Immunoglobulin Light-chain Amyloidosis - blood
Immunoglobulin Light-chain Amyloidosis - diagnosis
Immunoglobulin Light-chain Amyloidosis - epidemiology
Immunoglobulin Light-chain Amyloidosis - urine
Kidney Diseases - diagnosis
Kidney Diseases - epidemiology
Kidney Diseases - etiology
Male
Medicine
Medicine & Public Health
Middle Aged
Nephrology
Nephrology Crossing Borders
Nephrotic Syndrome - urine
Proteinuria - etiology
Registries
Retrospective Studies
Urology
title Biochemical profile of renal amyloidosis in a Latin American cohort
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T08%3A33%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biochemical%20profile%20of%20renal%20amyloidosis%20in%20a%20Latin%20American%20cohort&rft.jtitle=Journal%20of%20nephrology&rft.au=Carretero,%20Marcelina&rft.date=2024-11-01&rft.volume=37&rft.issue=8&rft.spage=2351&rft.epage=2354&rft.pages=2351-2354&rft.issn=1724-6059&rft.eissn=1724-6059&rft_id=info:doi/10.1007/s40620-024-02046-y&rft_dat=%3Cproquest_cross%3E3100275648%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c228t-b397260c01385b563a28c27be7d736ebdc8d63b56bfdae4bcd98c1bac53dc5d43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3100275648&rft_id=info:pmid/39225979&rfr_iscdi=true